10-86446384-A-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_015045.5(WAPL):c.3180T>A(p.Asp1060Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000427 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015045.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WAPL | NM_015045.5 | c.3180T>A | p.Asp1060Glu | missense_variant | 16/19 | ENST00000298767.10 | |
WAPL | NM_001318328.2 | c.3162T>A | p.Asp1054Glu | missense_variant | 16/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WAPL | ENST00000298767.10 | c.3180T>A | p.Asp1060Glu | missense_variant | 16/19 | 1 | NM_015045.5 | P1 | |
WAPL | ENST00000372075.2 | c.873T>A | p.Asp291Glu | missense_variant | 7/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251416Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135884
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 727232
GnomAD4 genome AF: 0.000210 AC: 32AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2022 | The c.3180T>A (p.D1060E) alteration is located in exon 16 (coding exon 15) of the WAPL gene. This alteration results from a T to A substitution at nucleotide position 3180, causing the aspartic acid (D) at amino acid position 1060 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at